NVCR long Like the volume and the high wave indecision candle.
Great spacing between the moving averages, offering great risk reward.
Looking for a pull back to get in with a limit buy
Key stats
About NovoCure Limited
Sector
Industry
CEO
Asaf Danziger
Website
Headquarters
St. Helier
Founded
2000
ISIN
BRN2VCBDR008
FIGI
BBG014XJ1BC3
NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.
NVCRNuovo cure consolidating under 200 dma , but above 65 ema , Pradeep Bonde says 65 ema cross is better then 200 ema
Long short term / short long termKeeping it simple here. Given the current market conditions, it could play out in a h&S pattern with a target of around 15 bucks. What do you think?
NVCR ready to go on an extended run Initial Target by Apr 14 = 99
Target Range by 5/20/2022 = 108-116
Upcoming earnings as a catalyst. Bullish Momentum for pre-earnings run up.
Kept the chart simple but a lot of bullish aspects at play here, to name a few:
- ready for markup coming off an accumulation phase
- completes wave 5 corre
NVCR primed for an extended runKept the chart simple but there are a lot of bullish aspects at play here:
- ready for markup after an accumulation phase
- coming off a wave 5 correction apprx. 0.786 off the highs last June
- looking at weekly chart you’ll see a larger running flat structure
- earnings as a catalyst and overall
NVCR - SwingSwing trade - longer term. Could enter between 90/92 or wait for more bullish momentum and catch it on the pullback.
NVCRWatching, in a heavy buy zone, ADX/DI about to cross bullish with RSI divregence. Hasnt been able to close above the 20 EMA since JUN, that will be my final buy trigger. Huge potential.
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
